|
US7759495B2
(en)
*
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP2170863B1
(en)
*
|
2007-07-05 |
2015-09-02 |
Array Biopharma, Inc. |
Pyrimido cyclopentanes useful for the treatment of inflammatory or hyperproliferative diseases
|
|
JP5314053B2
(ja)
*
|
2008-02-12 |
2013-10-16 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎ウイルス阻害剤
|
|
BRPI0907733A2
(pt)
|
2008-02-12 |
2015-07-14 |
Bristol Myers Squibb Co |
Inibidores do vírus da hepatite c
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CA2721060A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
US8541424B2
(en)
|
2008-12-23 |
2013-09-24 |
Abbott Laboratories |
Anti-viral compounds
|
|
US8546405B2
(en)
|
2008-12-23 |
2013-10-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2210882A1
(en)
*
|
2009-01-16 |
2010-07-28 |
Commissariat à l'Énergie Atomique et aux Énergies Alternatives |
Synthesis of new protected azahistidine, their processes and their use in synthesises
|
|
US8188132B2
(en)
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
TWI438200B
(zh)
*
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
Ｃ型肝炎病毒抑制劑
|
|
US8242156B2
(en)
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
CA2753313A1
(en)
*
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
CN102427731B
(zh)
|
2009-02-27 |
2015-05-13 |
英安塔制药有限公司 |
丙型肝炎病毒抑制剂
|
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US9765087B2
(en)
|
2009-02-27 |
2017-09-19 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8507522B2
(en)
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
CN102427726B
(zh)
*
|
2009-03-27 |
2014-10-08 |
普雷西迪奥制药公司 |
丙型肝炎的稠环抑制剂
|
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
RU2541571C2
(ru)
|
2009-04-15 |
2015-02-20 |
Эббви Инк. |
Противовирусные соединения
|
|
EA027493B1
(ru)
*
|
2009-05-13 |
2017-07-31 |
Джилид Фармассет Ллс |
Промежуточные соединения для получения противовирусного соединения
|
|
US8211928B2
(en)
*
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8772505B2
(en)
*
|
2009-05-29 |
2014-07-08 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C
|
|
AU2010253791A1
(en)
|
2009-05-29 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C
|
|
US8937150B2
(en)
*
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8716454B2
(en)
|
2009-06-11 |
2014-05-06 |
Abbvie Inc. |
Solid compositions
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
ES2414934T3
(es)
|
2009-06-11 |
2013-07-23 |
Abbvie Bahamas Limited |
Inhibidores del virus de la Hepatitis C
|
|
AU2012203474B2
(en)
*
|
2009-06-11 |
2014-09-18 |
Abbvie Ireland Unlimited Company |
Anti-Viral Compounds
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
JP2012533569A
(ja)
|
2009-07-16 |
2012-12-27 |
ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド |
フラビウイルス感染症を治療又は予防するためのベンゾイミダゾール類似体
|
|
WO2011028596A1
(en)
|
2009-09-04 |
2011-03-10 |
Glaxosmithkline Llc |
Chemical compounds
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8927709B2
(en)
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011031904A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
EP2503881B1
(en)
|
2009-11-25 |
2015-05-13 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
|
US20110137633A1
(en)
*
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Anti-viral compounds and methods of identifying the same
|
|
MY179840A
(en)
*
|
2009-12-04 |
2020-11-18 |
National Health Res Inst |
Proline derivatives
|
|
WO2011081918A1
(en)
|
2009-12-14 |
2011-07-07 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
BR112012014899A2
(pt)
*
|
2009-12-18 |
2017-03-14 |
Idenix Pharmaceuticals Inc |
composto, composição farmacêutica, método para tratar ou prevenir uma infecção por vírus de hepatite c em um sujeito, método para tratar , prevenir ou melhorar um ou mais sintomas de uma doença hepática ou distúrbio associado a uma infecção por vírus de hepatite c em um sujeito, método para inibir a replicação de um vírus em um hospedeiro, método para inibir a replicação de um vírus
|
|
AU2010341537A1
(en)
*
|
2009-12-22 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Compounds and methods of use thereof for the treatment of viral diseases
|
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
JP2013518060A
(ja)
|
2010-01-25 |
2013-05-20 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
Ｃ型肝炎ウイルス阻害剤
|
|
US8623814B2
(en)
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
CN102858157A
(zh)
|
2010-03-04 |
2013-01-02 |
埃南塔制药公司 |
作为hcv复制的抑制剂的组合药物活性剂
|
|
US8609635B2
(en)
|
2010-03-09 |
2013-12-17 |
Merck Sharp & Dohme Corp. |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
CA2794145A1
(en)
*
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US9127021B2
(en)
|
2010-04-09 |
2015-09-08 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
EP2575819A4
(en)
|
2010-06-04 |
2013-11-27 |
Enanta Pharm Inc |
INHIBITORS OF HEPATITIS C VIRUS
|
|
NZ605440A
(en)
*
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
EP2585448A1
(en)
|
2010-06-28 |
2013-05-01 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
AR081691A1
(es)
|
2010-06-28 |
2012-10-10 |
Vertex Pharma |
Derivados de tiofeno, metodos para su preparacion y su uso en el tratamiento o la prevencion de infecciones por flavivirus
|
|
JP2013541499A
(ja)
|
2010-07-26 |
2013-11-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
置換されたビフェニレン化合物およびウイルス性疾患の治療のためのその使用方法
|
|
EP2603080A4
(en)
|
2010-08-12 |
2014-01-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
EP2606041A2
(en)
|
2010-08-17 |
2013-06-26 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flaviviridae viral infections
|
|
EP2963034A1
(en)
*
|
2010-08-26 |
2016-01-06 |
RFS Pharma, LLC. |
Potent and selective inhibitors of hepatitis c virus
|
|
US8822520B2
(en)
|
2010-09-22 |
2014-09-02 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic HCV inhibitors
|
|
CN103124722B
(zh)
*
|
2010-09-22 |
2014-11-12 |
三井化学Agro株式会社 |
具有含氟氨基甲酸酯基的氨基酸酰胺衍生物的制造方法、其制造中间体、及乙二胺衍生物的制造方法
|
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
|
AU2011314168A1
(en)
|
2010-09-29 |
2013-04-04 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
SI2692346T1
(sl)
*
|
2010-10-13 |
2016-03-31 |
Abbvie Bahamas Limited |
Antivirusni derivati 1-fenil-2,5-dibenzimidazol-5-il-pirolidina
|
|
AU2014203655B2
(en)
*
|
2010-10-13 |
2016-07-07 |
Abbvie Ireland Unlimited Company |
Anti-viral compounds
|
|
WO2012068234A2
(en)
|
2010-11-17 |
2012-05-24 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
RU2452735C1
(ru)
*
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
|
US20150232455A1
(en)
*
|
2010-12-15 |
2015-08-20 |
Allan C. Krueger |
Anti-viral compounds
|
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
|
US8552047B2
(en)
|
2011-02-07 |
2013-10-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
|
WO2012158861A2
(en)
|
2011-05-18 |
2012-11-22 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
|
|
WO2012162580A2
(en)
*
|
2011-05-26 |
2012-11-29 |
Abbvie Inc |
Anti-viral compounds
|
|
WO2012162578A2
(en)
*
|
2011-05-26 |
2012-11-29 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2013016499A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparation of thiophene compounds
|
|
WO2013016501A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Formulations of thiophene compounds
|
|
WO2013030750A1
(en)
|
2011-09-01 |
2013-03-07 |
Lupin Limited |
Antiviral compounds
|
|
US20140378416A1
(en)
|
2011-09-14 |
2014-12-25 |
Michael P. Dwyer |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
PH12014500557A1
(en)
|
2011-09-16 |
2014-05-26 |
Gilead Pharmasset Llc |
Methods for treating hcv
|
|
PL2907816T3
(pl)
|
2011-11-16 |
2019-03-29 |
Gilead Pharmasset Llc |
Skondensowane imidazolyloimidazole jako związki przeciwwirusowe
|
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
NZ628515A
(en)
|
2012-02-10 |
2016-06-24 |
Lupin Ltd |
Antiviral compounds with a dibenzooxaheterocycle moiety
|
|
US9012427B2
(en)
|
2012-03-22 |
2015-04-21 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
US20130309196A1
(en)
*
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
PL2855453T3
(pl)
|
2012-06-04 |
2017-05-31 |
Actelion Pharmaceuticals Ltd. |
Pochodne benzimidazoloproliny
|
|
JP6244365B2
(ja)
|
2012-10-10 |
2017-12-06 |
アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
［オルトビ−（ヘテロ−）アリール］−［２−（メタビ−（ヘテロ−）アリール）−ピロリジン−１−イル］−メタノン誘導体であるオレキシン受容体アンタゴニスト
|
|
US9233974B2
(en)
*
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
SG11201506021XA
(en)
|
2013-01-31 |
2015-08-28 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
|
WO2014134251A1
(en)
|
2013-02-28 |
2014-09-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
JP2014172851A
(ja)
*
|
2013-03-07 |
2014-09-22 |
Chiba Univ |
ピラゾール誘導体の製造方法およびイソオキサゾール誘導体の製造方法
|
|
EP2970241A1
(en)
|
2013-03-12 |
2016-01-20 |
Actelion Pharmaceuticals Ltd. |
Azetidine amide derivatives as orexin receptor antagonists
|
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
|
WO2014175699A1
(ko)
|
2013-04-26 |
2014-10-30 |
서울대학교 산학협력단 |
벤지딘 유도체, 이의 제조방법 및 이를 함유하는 c형 간염 바이러스에 의한 간질환 치료용 약학적 조성물.
|
|
KR101507914B1
(ko)
*
|
2013-04-26 |
2015-04-07 |
서울대학교산학협력단 |
신규한 바이페닐다이아마이드 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 c형 간염 바이러스 관련 간질환의 예방 또는 치료용 약학적 조성물
|
|
US9717712B2
(en)
|
2013-07-02 |
2017-08-01 |
Bristol-Myers Squibb Company |
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
|
|
US20150023913A1
(en)
|
2013-07-02 |
2015-01-22 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US9775831B2
(en)
|
2013-07-17 |
2017-10-03 |
Bristol-Myers Squibb Company |
Combinations comprising biphenyl derivatives for use in the treatment of HCV
|
|
EP3038601B1
(en)
|
2013-08-27 |
2020-04-08 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
|
US10167298B2
(en)
|
2013-10-30 |
2019-01-01 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
|
|
KR101628933B1
(ko)
*
|
2013-12-03 |
2016-06-10 |
서울대학교산학협력단 |
벤지딘 유도체, 이의 제조방법 및 이를 함유하는 c형 간염 바이러스에 의한 간질환 치료용 약학적 조성물
|
|
LT3077391T
(lt)
|
2013-12-04 |
2018-10-25 |
Idorsia Pharmaceuticals Ltd |
Benzimidazolo prolino darinių panaudojimas
|
|
WO2015089810A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
|
CN115197197A
(zh)
*
|
2014-05-09 |
2022-10-18 |
艾伯维公司 |
晶型
|
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
|
US20160375017A1
(en)
|
2015-06-26 |
2016-12-29 |
Abbvie Inc. |
Solid Pharmaceutical Compositions for Treating HCV
|
|
WO2017023631A1
(en)
|
2015-08-06 |
2017-02-09 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
KR101766822B1
(ko)
*
|
2015-09-10 |
2017-08-24 |
서울대학교산학협력단 |
디페닐설페이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 c형 간염 바이러스 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
CN109020821A
(zh)
*
|
2017-06-12 |
2018-12-18 |
上海百灵医药科技有限公司 |
一种l-n,n-二甲基苯丙氨酸的合成方法
|
|
EP3891508A1
(en)
|
2018-12-04 |
2021-10-13 |
Bristol-Myers Squibb Company |
Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring
|
|
AU2022279234B2
(en)
|
2021-05-21 |
2025-08-28 |
Gilead Sciences, Inc. |
Pentacyclic derivatives as zika virus inhibitors
|
|
CN117321059A
(zh)
|
2021-05-21 |
2023-12-29 |
吉利德科学公司 |
用于治疗寨卡病毒感染的四环化合物
|